Tag: Seaport Therapeutics
Seaport Therapeutics secures $100M to harness Monash invention
Seaport Therapeutics, a biopharmaceutical company in the clinical stage, centred on an innovative drug delivery system initially created by researchers from Monash University, announced the completion of a Series A funding round, which raised USD 100 million (AUD 154 million).
Featured Article
Australian manufacturing in 2025: Challenges and pathways to progress
The Australian manufacturing sector, long considered the backbone of the nation’s economy, is standing at a crossroads in 2025.
